ASH in three months: buy, wait or sell?
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
- Buy / Wait / Sell rating
- 3-month target price
- Bear · Base · Bull
- vs. the market
What happened with ASH today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
Ashland supplies manufacturers with ingredients that help medicines, personal-care products and industrial materials work as intended. Drugmakers buy its ingredients to bind tablets, control drug release and apply coatings; consumer-product formulators use them to adjust texture, stability and other properties. Paint and construction-material manufacturers buy additives that control thickness and improve performance. These businesses generate most of Ashland’s sales, with pharmaceutical and nutrition ingredients the largest segment. A smaller business sells chemical intermediates and supplies raw materials to Ashland’s other operations.
Cellulose-based materials and polyvinylpyrrolidone polymers, known as PVP, together account for most revenue across these markets. Sales are not concentrated in a single dominant customer.
The business depends on customers continuing to use Ashland’s materials in their formulations and on developing ingredients that meet changing requirements. Its ability to pass raw-material and energy cost increases on to customers also matters. Products and operations must comply with applicable food, drug, chemical and environmental rules, including FDA requirements and Europe’s REACH chemical regulation.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
Ashland’s results hinge chiefly on pharmaceutical and personal-care ingredient demand and cellulosics/PVP pricing, making BASF a competitor to watch even though it is absent from this list.
Dow competes with Ashland for construction-chemical business and also supplies ingredients that improve coatings and consumer-product formulations. Watch Dow’s coatings and construction business for clues to demand in markets served by Ashland’s additives.
Innospec Inc. and Ashland compete to supply ingredients for personal-care formulations and chemicals used in drilling, well completion and oil production, giving them overlapping customer demand.
Eastman Chemical Company competes with Ashland for coatings and other formulation customers, selling additives that improve product performance and cellulose-based materials.
Stepan Co. competes with Ashland to supply household-cleaning, personal-care and industrial-product manufacturers with surfactants and other formulation ingredients.
PPG Industries’ paint production reflects demand for the thickeners and performance additives Ashland sells to paint manufacturers; PPG sells coatings to contractors, consumers and industrial customers. Watch its architectural and industrial coatings business for clues to Ashland’s coatings-additive demand, rather than evidence of a direct supply relationship.
Ashland buys cosmetic ingredients from United-Guardian, Inc. and resells them to cosmetic and personal-care manufacturers, acting as its exclusive distributor in many territories. Sales to Ashland accounted for approximately 22% of United-Guardian’s total sales in 2025, making that sales line a direct window into Ashland’s purchases from this supplier.
Housing Starts (Sep)
Ashland sells architectural-coatings additives and construction products, so measures of new-home building track activity among customers whose purchases can support its sales.
Expected1.31MLast release1.275M
If it comes in above expectations
If the reading is above the 1.31M estimate, it is above the previous 1.275M. More homebuilding than expected could increase coatings and construction customers’ need for Ashland’s additives and products, supporting sales.
If it comes in below expectations
Less homebuilding than expected could reduce coatings and construction customers’ need for Ashland’s additives and products, weighing on sales.
EIA Crude Oil Stocks Change (Oct/16)
Ashland’s hydrocarbon-derived raw materials and energy are exposed to oil-market costs it cannot always pass on, so US crude and gasoline stocks help indicate potential pressure on its production costs and margins.
Falling crude and gasoline stocks point to tighter supply and potential upward pressure on oil and fuel costs; rising stocks point to looser supply and potential cost relief for Ashland, though pass-through to customers is not assured.
PPG Industries, Inc. earningsPPG
PPG’s report will show whether coatings production is strengthening, offering a clue to demand for Ashland’s coatings additives.
Look at PPG’s architectural and industrial coatings businesses. Strength in both would suggest coatings customers’ production and demand are better supported, lending support to the market for Ashland’s additives; weakness would point to less need for production inputs and pressure on Ashland’s coatings-additive demand. PPG sells coatings; it is not identified as a direct supplier of Ashland’s additives.
Fed Interest Rate Decision
Ashland’s $1.384 billion of debt makes Fed decisions relevant because they influence the rates it may pay when refinancing debt, including $586 million due in fiscal 2028.
Expected4.0%Last release4.0%
If it comes in above expectations
If the Fed sets rates higher than expected, refinancing could cost more and raise Ashland’s interest expense, leaving less cash for operations, investment or debt repayment.
If it comes in below expectations
If the Fed sets rates lower than expected, refinancing could cost less and reduce Ashland’s interest expense, leaving more cash for operations, investment or debt repayment.
Ashland Inc. earningsThis company
Ashland’s report will show whether sales and segment operating results for its cellulosics and polyvinylpyrrolidone products are stabilizing.
Read sales alongside segment operating results in Life Sciences and Specialty Additives. Both segments rely heavily on cellulosics, and polyvinylpyrrolidone is another major product. Improvement in both would point to recovering demand and profitability in core products; continued weakness, even if Personal Care holds up, would mean Ashland’s recovery remains uneven.
Industrial Production MoM (Oct)
Ashland sells specialty additives and BDO derivatives to industrial producers, so factory, mine and utility output tracks activity that can shape those customers’ purchases and Ashland’s sales.
Rising factory, mine and utility output points to firmer demand for industrial inputs and may support purchases of Ashland’s additives and BDO derivatives; falling output points to weaker demand and potentially lower purchases.